You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Oligonucleotide Enzyme Surrogate (OnES)

    SBC: Accacia International LLC            Topic: CBD08108

    Historically organophosphorus compounds such as insecticides and nerve agents have been susceptible to decomposition by proteinaceous enzymes. Organophosphate hydrolases (OPH) represent a practical method to deactivate such compounds peripherally and on surfaces. However, when such organophosphates are ingested, the use of proteinaceous enzymes such as OPH can be problematic because of their tende ...

    SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense
  2. Ribozymes for In Vivo Degradation of G-Nerve Agents

    SBC: AGAVE BIOSYSTEMS INC.            Topic: CBD08108

    Given the possibility to administer prophylactic doses of protein bioscavengers inactivating OP nerve agents before they reach their acetylcholinesterase target, much attention has been given to proteins such as human butyrylcholinesterase and paraoxonase I. As small nucleic acid catalysts can exhibit triphosphoesterase activities, the identification of new molecules active against nerve agents w ...

    SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense
  3. Collective Protection for Military Working Dogs

    SBC: AGAVE BIOSYSTEMS INC.            Topic: CBD08103

    Shelter enclosures for military working dogs in the event of a CB attack is a technology gap identified by the Joint Requirements Office. Important parameters to consider in the design of protective enclosures include low weight and size to minimize transport requirements; rapid setup; and accommodation of canine physiological and psychological comfort needs. The overall operational weight of th ...

    SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense
  4. Sustainable Production of Pinfish (Lagodon rhomboides) for the Live Bait Market

    SBC: AQUATIC INNOVATIONS            Topic: N/A

    Recreational saltwater fishing is a major industry in coastal areas of the United States. The U.S. Fish and Wildlife Service estimated that saltwater anglers spent $8.4 billion in 2001 on fishing trips and supplies. In many communities this type of "wildlife tourism" is the lifeblood of the community. It is vital to these communities to have a consistent supply of needed goods for these anglers. T ...

    SBIR Phase I 2008 Department of Agriculture
  5. Rapid enzyme-based assays to detect banned substances in food

    SBC: BIOO SCIENTIFIC CORPORATION            Topic: N/A

    It is important to test the food supply for known toxic or banned substances which can impinge public safety. While a number of high-throughput tests have been developed to screen the food supply for higher molecular weight banned substances, it has been difficult to develop methods to comprehensively screen the food supply for low molecular weight banned substances such as histamine or pentachlor ...

    SBIR Phase I 2008 Department of Agriculture
  6. Multiple Indication Adjuvants

    SBC: BIOPROTECTION SYSTEMS CORP.            Topic: CBD08105

    The objective of this study is to demonstrate the efficacy and broad applicability of the human immune-modulating alphaGal Adjuvant Technology for antiviral vaccine development. We will use viral vaccine candidates for the select Category A viral pathogens Zaire ebolavirus (ZEBOV, filovirus), Rift Valley fever virus (RVFV, bunyavirus), and Lassa virus (LV, arenavirus), to evaluate the adjuvant pot ...

    SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense
  7. Hybrid System for Ultrasound Signal, Spectral, and Image Analyses to Enhance Meat Quality Evaluation in Food Animals

    SBC: BIOTRONICS, INC            Topic: N/A

    Determining meat quality attributes in food animals is essential for genetic selection, sorting, and marketing. Ultrasound techniques have the potential to benefit the swine industry for improvements in both quality and yield measures by non-destructive means. There is a need to continually improve percentage intramuscular fat estimation accuracy and reduced bias, especially before integration of ...

    SBIR Phase I 2008 Department of Agriculture
  8. Complete Plant Growth Medium for Construction of Golf Greens

    SBC: CHK GROUP, INC.            Topic: N/A

    This project will increase the water and fertilizer use efficiency to create an environmentally friendly green golf courses. Successful completion of the proposed innovation by ChK Group, Inc., is expected to validate our preliminary findings and help the company establish strategic partnerships with manufacturers of golf-green accessories and golf-course owners/managers. The proposed innovation w ...

    SBIR Phase I 2008 Department of Agriculture
  9. Ambient Processing and Nutritional Assessment of Trypsin-Inhibitor-Null Soybean Products

    SBC: SCHILLINGER SEED INC            Topic: N/A

    Commercial soybeans require heat processing to deactivate anti-nutrition factors/enzymes. Schillinger Seed has developed a new soybean free of the key anti-nutrition Kunitz Tyrpsin Inhibitor (SKTI-Null). This new SKTI-Null) soybean presents the opportunity for ambient or cold processing of soybeans for use in food and feed. The elimination of heat processing eliminates the need of a signifcant amo ...

    SBIR Phase I 2008 Department of Agriculture
  10. Blood Brain Barrier (BBB) Permeable Encapsulating Agents for Effective Delivery of CNS-active Agents

    SBC: LYNNTECH INC.            Topic: CBD08107

    Drug transport in the central nervous system is highly regulated by the Blood-Brain Barrier (BBB). Most medicines, including many for treating cancer, Alzheimer’s, and stroke, do not meet essential criteria, such as lipophilicity and low molecular weight, required for appreciable transport into the brain. However, endogenous peptides, such as insulin or transferrin, and certain monoclonal anti ...

    SBIR Phase I 2008 Department of DefenseOffice for Chemical and Biological Defense
US Flag An Official Website of the United States Government